Phase 3 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have had surgery to fully remove stomach cancer or cancer at the junction between the stomach and the food pipe, with the aim of curing the disease
- People whose cancer is classified as stage IB (using a specific medical staging system) and who also have at least one additional factor that raises the risk of the cancer coming back — these factors include being over 65 years old, being male, or having certain features found in the cancer tissue when examined under a microscope (confirm with trial site)
- People aged between 18 and 74 years old
- People who are well enough to carry out daily activities, with only mild limitations at most (based on a standard health scale used in clinical trials)
- People whose blood counts, kidney function, and liver function are within acceptable ranges as measured by blood tests
Who may not be able to join:
- Women who are pregnant or breastfeeding
- Women who could become pregnant and have a positive pregnancy test at the start of the trial, or who have not gone without a menstrual period for at least 12 months (if postmenopausal)
- People who are sexually active and able to have children but are unwilling to use contraception during the trial and for 3 months after finishing the study treatment
- People who show any signs that the cancer has spread to other parts of the body
- People who have already had chemotherapy or radiation treatment for this stomach cancer
- People who have not yet recovered from serious complications following their stomach surgery
- People who have had another cancer in the last five years, with the exception of certain fully treated skin cancers or a specific type of fully treated cervical condition
- People with uncontrolled seizures, significant nervous system disorders, or serious mental health conditions that the trial doctors believe would affect the person's ability to give informed consent or follow the treatment plan
- People with significant heart problems, such as unstable chest pain, moderate to severe heart failure, serious irregular heartbeat requiring medication, or a heart attack within the last 6 months
- People who have difficulty absorbing food or medication through their digestive system, or who are unable to swallow tablets
- People with serious ongoing infections or other serious uncontrolled health conditions
- People who have received a transplanted organ and are taking medication to prevent rejection
- People who have taken part in another clinical trial or received an experimental treatment within 4 weeks before joining this trial
- People who need to take a specific antiviral medicine called sorivudine or closely related drugs such as brivudine
- People who test positive for HIV
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Min-Hee Ryu, MD, PhD, Asan Medical Center
Phone: +82230105935
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
recurrence-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.